Aiden Flynn, founder of Exploristics discusses medication adherence in clinical trials using data simulations on the "People Always, Patients Sometimes" podcast.
Tom Rhoads gave a keynote presentation at eyeforpharma virtual that challenged the clinical trials industry to be open to new patient expectations based on COVID-19.
We’ve invited some special guests in recognition of Heart Failure Awareness Week from UNC Eshelman School of Pharmacy and UNC REX Hospital.
Clinical trials haven’t changed much in decades. These industry leaders show us why it’s time for disruption – and how to make it happen. Spencer Health Solutions is proud to present the Voices of Disruption.
Voices of Disruption is a discussion among patients and pharma industry leaders about obstacles to change in clinical trials produced by Spencer Health Solutions.
Three years in the market, the spencer Direct-to-Patient platform is consistently demonstrating a new standard of greater than 95% adherence among chronically-ill patients.
Royal Philips and Spencer Health Solutions expand partnership to Europe. Chronically ill patients in selected EU countries to benefit from in-home medication adherence and telehealth platform.
As the FDA supports innovative trial designs and pharmaceutical companies seek ways to bring new trials to market faster at lower costs, technology that makes the patient experience easier and supports the research goals is poised to change the landscape.
To understand the enormity of Spencer’s potential in the drug development realm, it’s important to understand one of the industry’s most common barriers.